Lifestyle Modification for MAFLD Based on TTM
Lifestyle Modification for the Treatment of Metabolic Associated Fatty Liver Disease Based on Transtheoretical Model: a Single-center, Randomized, Controlled Study
Sponsor: Nanfang Hospital, Southern Medical University
This NA trial investigates Metabolic Associated Fatty Liver Disease and is currently ongoing. Nanfang Hospital, Southern Medical University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Feb 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2021 — Jul 2023 [monthly]
Recruiting NA
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nanfang Hospital, Southern Medical University
For direct contact, visit the study record on ClinicalTrials.gov .